VICTORIA HATFIELD: Open Payments
NPI 1013302892 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,737 in 70 payments from 20 companies in 2025. Trend: 2023 $1,477 · 2024 $958 · 2025 $1,737
Food & beverage: $1,728Education: $10
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $289 |
| UCB, Inc. | 10 | $237 |
| Amgen Inc. | 6 | $167 |
| Galderma Laboratories, L.P. | 4 | $139 |
| ABBVIE INC. | 11 | $139 |
| Botanix SB Inc | 2 | $121 |
| Lilly USA, LLC | 4 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| PFIZER INC. | 3 | $60 |
Products named: DUPIXENT, Bimzelx, Otezla, SOFDRA, SKYRIZI, TALTZ, COSENTYX, Sotyktu.
Industry payments across DC — which companies pay providers there.
